Statizoid

South-East Asia (WHO region): statistics and indicators

192 indicators and 4,794 data points for South-East Asia (WHO region), collected automatically from official statistical sources.

Indicators
192
Data points
4,794

Browse South-East Asia (WHO region) data by subject

Key indicators for South-East Asia (WHO region)

IndicatorLatest YearRank Trend
Pertussis - number of reported cases 2,449 2025 11th volatile
Total tetanus - number of reported cases 164 2025 10th volatile
Diphtheria - number of reported cases 3,416 2025 6th volatile
Measles - number of reported cases 19,075 2025 10th volatile
Neonatal tetanus - number of reported cases 84 2025 8th volatile
Underweight among adults, BMI < 18.5 kg/m2 (crude estimate) 12.0% 2024 2nd falling
Overweight among adults, BMI ≥ 25 kg/m2 (crude estimate) 32.5% 2024 9th volatile
Obesity among adults, BMI ≥ 30 kg/m2 (age-standardized estimate) 8.3% 2024 11th volatile
Overweight among adults, BMI ≥ 25 kg/m2 (age-standardized estimate) 32.5% 2024 9th volatile
Obesity among children and adolescents, BMI-for-age > +2 standard 5.6% 2024 9th volatile
Overweight among children and adolescents, BMI-for-age > +1 standard 12.6% 2024 10th volatile
Obesity among adults, BMI ≥ 30 kg/m2 (crude estimate) 8.2% 2024 11th volatile
Underweight among adults, BMI < 18.5 kg/m2 (age-standardized estimate) 12.1% 2024 2nd falling
Thinness among children and adolescents, BMI-for-age < -2 standard 18.8% 2024 1st falling
Number of infant deaths 678,154 2024 6th falling
Number of under-five deaths 782,382 2024 6th volatile
Number of neonatal deaths 482,570 2024 5th falling
Neonatal mortality rate 16.41 2024 6th falling
Infant mortality rate (probability of dying between birth and age 1) 23.13 2024 6th falling
Under-five mortality rate 26.66 2024 6th falling
Number of maternal deaths 32,702 2023 4th volatile
Maternal mortality ratio 96.26 2023 4th volatile
Adolescent mortality rate 2.15 2024 6th falling
Mortality rate for 5-14 year-olds 4.09 2024 6th falling
Number of deaths among adolescents 67,025 2024 5th falling
Number of deaths among children 5 to 14 years of age 124,957 2024 5th falling
Number of deaths among children ages 5 to 9 years 57,932 2024 6th volatile
Proportion of population with primary reliance on polluting fuels and 39.3% 2023 4th falling
Population with primary reliance on clean fuels and technologies for 763.07 2023 2nd volatile
Women who have their need for family planning satisfied with modern 76.8% 2025 3rd rising
Diabetes treatment coverage, crude 28.37 2022 9th rising
Prevalence of diabetes, age-standardized 21.12 2022 2nd rising
Diabetes treatment coverage, age-standardized 28.84 2022 9th rising
Proportion of population with primary reliance on fuels and 37.5% 2023 4th falling
Hib (Hib3) immunization coverage among 1-year-olds (%) 94.0% 2025 1st volatile
Diphtheria tetanus toxoid and pertussis third-dose  (DTP3) 94.0% 2025 1st rising
Hepatitis B (HepB3) immunization coverage among 1-year-olds (%) 94.0% 2025 1st volatile
Measles-containing-vaccine second-dose (MCV2) immunization coverage 93.0% 2025 1st volatile
Stunting numbers among children under 5 years of age (millions) 49,320 2024 6th falling
Overweight numbers among children under 5 years of age (thousands) 5,511 2024 10th rising
Overweight prevalence among children under 5 years of age (%) 3.3% 2024 13th rising
Mean HDL cholesterol, age-standardized 1.1 2018 7th flat
Mean Non-HDL cholesterol, age-standardized 3.3 2018 6th rising
Mean HDL cholesterol, crude 1.1 2018 7th flat
Mean Non-HDL cholesterol, crude 3.3 2018 6th rising
Mean total cholesterol, age-standardized 4.3 2018 7th flat
Number of deaths among children ages 10 to 14 years 81,507 2021 3rd falling
Alcohol, total per capita (15+) consumption (in litres of pure) 4.04 2024 5th rising
Proportion of population with primary reliance on clean fuels and 60.0% 2024 4th volatile
Number of incident tuberculosis cases 3.68 million 2024 3rd falling
Incidence of tuberculosis 201 2024 3rd falling
Number of incident tuberculosis cases 64,000 2024 6th volatile
Number of deaths due to tuberculosis, excluding HIV 433,000 2024 3rd falling
Deaths due to tuberculosis among HIV-negative people 24 2024 3rd falling
Population using at least basic drinking-water services 94.8% 2024 2nd rising
Population using at least basic sanitation services 80.5% 2024 4th rising
Tuberculosis - new and relapse cases 3.13 million 2024 3rd rising
Tuberculosis treatment coverage 85 2024 1st rising
Mean BMI (kg/m²) 22.2 2016 12th rising
Rubella - number of reported cases 2,940 2025 7th volatile
Treatment success rate: new TB cases 90 2023 3rd rising
Yellow fever - number of reported cases 0 2025 8th flat
Poliomyelitis - number of reported cases 1 2018 5th volatile
Mortality rate among children ages 10 to 14 years 2.63 2020 4th falling
UHC Service Coverage sub-index on infectious diseases 80 2023 8th rising
UHC Service Coverage sub-index on service capacity and access 73 2023 8th rising
UHC Service Coverage sub-index on reproductive, maternal, newborn and 70 2023 9th rising
UHC Service Coverage Index 68 2023 8th rising
UHC Service Coverage sub-index on noncommunicable diseases 53 2023 12th rising
Stillbirth rate 12.07 2023 6th falling
Rotavirus vaccines completed dose (RotaC) immunization coverage among 77.0% 2025 1st volatile
Current health expenditure (CHE) as percentage of gross domestic 5.3% 2023 11th rising
External health expenditure (EXT) as percentage of current health 5.4% 2023 7th flat
Domestic general government health expenditure (GGHE-D) as percentage 47.8% 2023 7th rising
Out-of-pocket expenditure as percentage of current health expenditure 41.0% 2023 2nd falling
Domestic general government health expenditure (GGHE-D) as percentage 2.9% 2023 7th rising
Domestic general government health expenditure (GGHE-D) as percentage 8.2% 2023 8th rising
Domestic private health expenditure (PVT-D) as percentage of current 46.8% 2023 2nd falling
Current health expenditure (CHE) per capita in US$ 244.94 2023 8th rising
Out-of-pocket expenditure (OOP) per capita in US$ 59.55 2023 8th rising
Domestic private health expenditure (PVT-D) per capita in US$ 69.45 2023 8th rising
Domestic general government health expenditure (GGHE-D) per capita in 167.49 2023 8th volatile
Mumps - number of reported cases 3,253 2025 11th volatile
Incidence of tuberculosis (per 100 000 population) 4.7 2023 6th volatile
Congenital Rubella Syndrome - number of reported cases 77 2025 8th volatile
External health expenditure (EXT) per capita in US$ 8 2023 8th volatile
Raised blood pressure (SBP>=140 OR DBP>=90) 26.33 2019 7th falling
Raised blood pressure (SBP>=140 OR DBP>=90) 25.7 2019 9th flat
Hypertension effective treatment coverage (controlled hypertension) 13.6% 2019 9th volatile
Hypertension: effective treatment coverage (controlled hypertension) 13.3% 2019 9th volatile
Hypertension treatment coverage among adults aged 30-79 with 31.0% 2019 9th rising
Hypertension treatment coverage among adults aged 30-79 with 31.8% 2019 9th rising
Pneumococcal conjugate second or third-dose vaccines (PCVc) 92.0% 2025 1st volatile
Adolescent birth rate 0.287 2025 5th volatile
Treatment success rate: previously treated TB cases 90 2023 1st rising
Prevalence of insufficient physical activity among adults aged 18+ 43.2% 2022 1st rising
Prevalence of insufficient physical activity among adults aged 18+ 43.7% 2022 1st rising
Estimated number of people (all ages) living with HIV 3.60 million 2025 4th falling
Prevalence of HIV among adults aged 15 to 49 0.2% 2025 5th falling
TB patients with known HIV status 89.0% 2024 2nd volatile

Share, cite or embed this page

Cite this page

South-East Asia (WHO region): statistics and indicators. Statizoid, drawing on Statizoid. Retrieved 24 August 2026, from https://statizoid.com/place/south-east-asia-who-region/

Embed or link this data

Paste this into a page to link back to these figures. The data itself is free to reuse under the original publishers' licences; please keep the attribution.

<a href="https://statizoid.com/place/south-east-asia-who-region/">South-East Asia (WHO region): statistics and indicators</a> — Statizoid